Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Apr 13, 2023 12:46pm

231 Views

Post# 35393298

RE: FDA 505 B2....that be NEW drug application into the FDA

and...as stated in the investor deck....with their "pharma partner".

Does anyone have access to the FDA's new drug applications? We know it's LABS per 505 B2....but which big pharma name sits on the actual NDA submission.

Oh, fun and games and the FDA Q1 site approval in Barrie means good things are well on the way.

For you nickle and dime millenials, try shorting over 5 billion shares of Pfizer's stock. Good luck, it only take about $20 to $30 billion to make a small dent.

LOL @ You!!!

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week